Albert Schmidbauer 100% Austrian science in every product Handcrafted production uncompromising since 2006 Eco-friendly packaging in the BIOGENA GreenPE bottle Research & development at the highest level with the largest scientific team in the industry Double Climate Positive Production of our premium supplements At BIOGENA, quality knows no compromises
12/1/2025 On November 6, 2025, the Trump administration announced a landmark agreement with pharmaceutical manufacturers Eli Lilly and Novo Nordisk to provide steep discounts on their most popular GLP-1 medications, cuts that will benefit Medicare and Medicaid enrollees as well as cash-paying patients
Pauling This Pharmacology Consult will focus on GLP-1 receptor agonists that are currently FDA approved for weight loss, including semaglutide (Wegovy, Novo Nordisk) and liraglutide (Saxenda, Novo Nordisk), but other FDA-approved options exist, such as orlistat, naltrexone/bupropion and phentermine/topiramate
Think of it this way: when you improve the energy efficiency of your cells, the benefits arent confined to just one area